Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient

Yuko Kawahara, Toru Yamashita, Yasuyuki Ohta, Kota Sato, Keiichiro Tsunoda, Mami Takemoto, Nozomi Hishikawa, Jun Eguchi, Koji Abe

Research output: Contribution to journal › Letter

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)144-146
Number of pages3
JournalJournal of the Neurological Sciences
Volume373
DOIs
Publication statusPublished - Feb 15 2017

Fingerprint

Immunologic Adjuvants
Chylomicrons
Lipoprotein Lipase
Hypertriglyceridemia
Interferon-beta
Demyelinating Diseases
Interferons
Therapeutics
Interferon beta-1a

Keywords

  • Chylomicron
  • Clinically isolated syndrome
  • Hypertriglyceridemia
  • Interferon-β
  • Lipoprotein lipase

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient. / Kawahara, Yuko; Yamashita, Toru; Ohta, Yasuyuki; Sato, Kota; Tsunoda, Keiichiro; Takemoto, Mami; Hishikawa, Nozomi; Eguchi, Jun; Abe, Koji.

In: Journal of the Neurological Sciences, Vol. 373, 15.02.2017, p. 144-146.

Research output: Contribution to journal › Letter

Kawahara, Y, Yamashita, T, Ohta, Y, Sato, K, Tsunoda, K, Takemoto, M, Hishikawa, N, Eguchi, J & Abe, K 2017, 'Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient', Journal of the Neurological Sciences, vol. 373, pp. 144-146. https://doi.org/10.1016/j.jns.2016.12.052
Kawahara Y, Yamashita T, Ohta Y, Sato K, Tsunoda K, Takemoto M et al. Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient. Journal of the Neurological Sciences. 2017 Feb 15;373:144-146. https://doi.org/10.1016/j.jns.2016.12.052
Kawahara, Yuko ; Yamashita, Toru ; Ohta, Yasuyuki ; Sato, Kota ; Tsunoda, Keiichiro ; Takemoto, Mami ; Hishikawa, Nozomi ; Eguchi, Jun ; Abe, Koji. / Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient. In: Journal of the Neurological Sciences. 2017 ; Vol. 373. pp. 144-146.
@article{570e99f137a44086b7ff22eca84fc513,
title = "Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient",
keywords = "Chylomicron, Clinically isolated syndrome, Hypertriglyceridemia, Interferon-β, Lipoprotein lipase",
author = "Yuko Kawahara and Toru Yamashita and Yasuyuki Ohta and Kota Sato and Keiichiro Tsunoda and Mami Takemoto and Nozomi Hishikawa and Jun Eguchi and Koji Abe",
year = "2017",
month = "2",
day = "15",
doi = "10.1016/j.jns.2016.12.052",
language = "English",
volume = "373",
pages = "144--146",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient

AU - Kawahara, Yuko

AU - Yamashita, Toru

AU - Ohta, Yasuyuki

AU - Sato, Kota

AU - Tsunoda, Keiichiro

AU - Takemoto, Mami

AU - Hishikawa, Nozomi

AU - Eguchi, Jun

AU - Abe, Koji

PY - 2017/2/15

Y1 - 2017/2/15

KW - Chylomicron

KW - Clinically isolated syndrome

KW - Hypertriglyceridemia

KW - Interferon-β

KW - Lipoprotein lipase

UR - http://www.scopus.com/inward/record.url?scp=85007568808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007568808&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2016.12.052

DO - 10.1016/j.jns.2016.12.052

M3 - Letter

C2 - 28131174

AN - SCOPUS:85007568808

VL - 373

SP - 144

EP - 146

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -

Access to Document